Chun, Felix
Felix Chun
VIAF ID: 269125391 ( Personal )
Permalink: http://viaf.org/viaf/269125391
Preferred Forms
- 100 1 _ ‡a Chun, Felix
- 100 1 _ ‡a Chun, Felix
- 100 0 _ ‡a Felix Chun
4xx's: Alternate Name Forms (7)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Amygdalin exerts antitumor activity in taxane-resistant prostate cancer cells | |
Antiangiogenic properties of axitinib versus sorafenib following sunitinib resistance in human endothelial cells — a view towards second line renal cell carcinoma treatment | |
Bladder cancer stage and mortality: urban vs. rural residency | |
CK5/6 and GATA3 defined phenotypes of muscle-invasive bladder cancer: impact in adjuvant chemotherapy and molecular subtyping of negative cases | |
Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy | |
Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy | |
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out | |
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups | |
effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients | |
effect of primary urological cancers on survival in men with secondary prostate cancer | |
Evaluation eines Clinical Decision Support System zur Unterstützung eines möglichst evidenzbasierten perioperativen Managements von antikoagulierten Patienten | |
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients | |
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy | |
Hämatologische Sicherheit der 177Lu-PSMA-617 Radioligandentherapie bei Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom | |
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy | |
Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making | |
Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies | |
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients | |
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant | |
Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores | |
Insulin-like growth factor-1 influences prostate cancer cell growth and invasion through an integrin alpha3, alpha5, alphaV, and beta1 dependent mechanism | |
Integrin alpha2 and beta1 cross-communication with mTOR/AKT and the CDK-cyclin axis in hepatocellular carcinoma cells | |
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer | |
Movember health care initiative 2019: prostate cancer screening at the University Hospital Frankfurt | |
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients | |
Olive mill wastewater inhibits growth and proliferation of cisplatin- and gemcitabine-resistant bladder cancer cells in vitro by down-regulating the Akt/mTOR-signaling pathway | |
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients | |
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | |
Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer | |
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer | |
Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors | |
Safety and efficacy of 177Lutetium-PSMA-617 radioligand therapy shortly after failing 223Radium-dichloride | |
significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better? | |
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma | |
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer | |
Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt | |
Wertigkeit der CD4-Zellzahlbestimmung in Diagnostik und Therapie von Harnwegsinfektionen und Urosepsis nach Nierentransplantation |